Back to ENLV

Enlivex Therapeutics Ltd. 6-K

Accession 0001213900-23-021234

Filing information

CIK
0001596812
Report date
2023-03-20
Filing date
2023-03-20
Form
6-K
Primary document
ea175376-6k_enlivex.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.